| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |